Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Androgen Independent Prostate Cancer”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Testing effectiveness (Phase 2)Study completedNCT00715078
What this trial is testing

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Who this might be right for
Prostate Cancer
Dendreon 122
Large-scale testing (Phase 3)Study completedNCT00519285
What this trial is testing

Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm Metastasis
Sanofi 1,224
Testing effectiveness (Phase 2)Study completedNCT00045227
What this trial is testing

Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00020046
What this trial is testing

Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00060437
What this trial is testing

Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00276549
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 35
Not applicableStudy completedNCT00499694
What this trial is testing

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT00090545
What this trial is testing

A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Study completedNCT00436956
What this trial is testing

AZD2171 to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT00417274
What this trial is testing

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Cancer
Cleveland BioLabs 31
Testing effectiveness (Phase 2)Study completedNCT00852007
What this trial is testing

A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1

Who this might be right for
Prostate Cancer
Hamilton Health Sciences Corporation 20
Testing effectiveness (Phase 2)Study completedNCT00569153
What this trial is testing

Safety Study of TAK-700 in Subjects With Prostate Cancer.

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 123
Testing effectiveness (Phase 2)Study completedNCT00181558
What this trial is testing

Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Massachusetts General Hospital 44
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)UnknownNCT02049190
What this trial is testing

Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerAndrogen-independent Prostate Cancer+1 more
Arno Therapeutics 75
Testing effectiveness (Phase 2)Study completedNCT00291005
What this trial is testing

PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolone

Who this might be right for
Prostatic Neoplasms
Sanofi 42
Testing effectiveness (Phase 2)Study completedNCT00068731
What this trial is testing

Lycopene in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Ended earlyNCT00638378
What this trial is testing

Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Incyte Corporation 22
Testing effectiveness (Phase 2)Study completedNCT00182741
What this trial is testing

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 19
Testing effectiveness (Phase 2)Study completedNCT00005857
What this trial is testing

Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Who this might be right for
Prostate Cancer
City of Hope Medical Center
Next Page